Repaglinide

Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not take if: Concomitant use of gemfibrozil
Known hypersensitivity to repaglinide or any inactive ingredients

What it is used for

PRANDIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitation of Use:

PRANDIN should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

Side effects, and when to stop

The following serious adverse reaction is also described elsewhere in the labeling:

Hypoglycemia

Who should not take it

PRANDIN is contraindicated in patients with:

Concomitant use of gemfibrozil
Known hypersensitivity to repaglinide or any inactive ingredients

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Repaglinide; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/repaglinide
APA 7th: sofidex. (2026, August 3). Repaglinide. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/repaglinide
AMA 11th: Repaglinide. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/repaglinide

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.